Journal article
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
Abstract
BACKGROUND: Salvage radiation therapy is often necessary in men who have undergone radical prostatectomy and have evidence of prostate-cancer recurrence signaled by a persistently or recurrently elevated prostate-specific antigen (PSA) level. Whether antiandrogen therapy with radiation therapy will further improve cancer control and prolong overall survival is unknown.
METHODS: In a double-blind, placebo-controlled trial conducted from 1998 …
Authors
Shipley WU; Seiferheld W; Lukka HR; Major PP; Heney NM; Grignon DJ; Sartor O; Patel MP; Bahary J-P; Zietman AL
Journal
The New England Journal of Medicine, Vol. 376, No. 5, pp. 417–428
Publisher
Massachusetts Medical Society
Publication Date
February 2, 2017
DOI
10.1056/nejmoa1607529
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAged, 80 and overAndrogen AntagonistsAnilidesCombined Modality TherapyDouble-Blind MethodFollow-Up StudiesGynecomastiaHumansIncidenceKaplan-Meier EstimateMaleMiddle AgedNeoplasm MetastasisNeoplasm Recurrence, LocalNeoplasm StagingNitrilesProstatectomyProstatic NeoplasmsRadiotherapySurvival RateTosyl Compounds